IPO
Company Snapshot
Sanofi is a Biotech company, based in Paris, France, founded 1973.
Recent changes
- Jul 24, 2026Jul 24, 2026Scribe Therapeutics Prices Upsized IPO With Sanofi Backing Pulse story
Latest Pulse
- Jul 24, 2026Scribe Therapeutics Prices Upsized IPO With Sanofi BackingGene-editing biotech Scribe Therapeutics priced an upsized IPO at $15 per share, raising $128.7 million with Sanofi as a strategic anchor investor, the first gene-editing IPO in over two years.→
- Jul 10, 2026Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPOScribe Therapeutics, the CRISPR biotech co-founded by Nobel laureate Jennifer Doudna, amended its S-1 to list on Nasdaq under ticker SCTX, backed by more than $180 million in Sanofi and Eli Lilly partnership payments.→
Coverage Timeline
newest firstAll Coverage
IPO$128.7M Raised
Scribe Therapeutics Prices Upsized IPO With Sanofi Backing
Gene-editing biotech Scribe Therapeutics priced an upsized IPO at $15 per share, raising $128.7 million with Sanofi as a strategic anchor investor, the first gene-editing IPO in over two years.
IPO
Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPO
IPO$180M+ partnership payments
Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPO
Scribe Therapeutics, the CRISPR biotech co-founded by Nobel laureate Jennifer Doudna, amended its S-1 to list on Nasdaq under ticker SCTX, backed by more than $180 million in Sanofi and Eli Lilly partnership payments.